JWH-073
From Wikipedia, the free encyclopedia
JWH-073
|
|
Systematic (IUPAC) name | |
naphthalen-1-yl-(1-butylindol-3-yl)methanone | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C23H21NO |
Mol. mass | 327.42 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
Legal |
Routes | ? |
JWH-073 is an analgesic drug from the aminoalkylindole family, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5x the affinity at CB2.[1] The abbreviation JWH stands for John W. Huffman, one of the inventors of the compound.
[edit] References
- ^ Aung MM, Griffin G, Huffman JW, et al (August 2000). "Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding". Drug Alcohol Depend 60 (2): 133–40. doi: . PMID 10940540.
|